Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Semiconductor test momentum is backed by repeated follow-on production orders, especially the 2026-08-12 $22M order from a lead wafer-level AI processor customer, plus a Q4 beat, record bookings/backlog, stronger fiscal 2027 outlook, and a 53% 21-day gain.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Liquidity ⢠Ongoing Losses ⢠Weak Cash Flow AEHR has exceptional liquidity and low leverage, but persistent losses, weak cash flow, and an extremely high valuation make it a high-risk investment pending sustained operational improvement.
Price Behavior
Key Price Behavior Insights: ⢠Strong rebound ⢠Resistance test ⢠Key support Support Level: $76.00â$81.00 Resistance Level: $94.70â$96.40 AEHR's rebound from $76.27 is constructive, but a sustained break above $94.70â$96.40 is needed to confirm stronger momentum while $76â$81 remains key support.
Sentiment & News
Key News Insights: ⢠AI Order Growth ⢠Record Backlog ⢠Insider Selling Aehr's AI-driven diversification, record backlog, and institutional interest support growth momentum, though elevated valuation and insider selling remain watchpoints.
AI Summary
AEHR is a high-risk execution trade on converting its AI, silicon-photonics, and hyperscale backlog into profitable, repeatable shipmentsânot merely an AI-equipment playâbecause its >50x sales valuation already assumes fiscal-2027 growth and margin recovery. Investors should demand sustained gross-margin, operating-income, and free-cash-flow improvement while watching concentrated-customer shipment timing and dilution risk.
Description
Aehr Test Systems designs and supplies test and burn-in equipment for logic, memory and optical integrated circuits, supporting both wafer-level and packaged-device verification. Its product set includes systems and handling solutions that enable full-wafer contact testing, singulated die and module burn-in, and compact single-wafer reliability checks across a range of device types and power levels. The company was incorporated in 1977 and is based in Fremont, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 13 | Aug 20 | AEHR | Aehr Test Systems | Semiconductor test momentum is backed by repeated follow-on production orders, especially the 2026-08-12 $22M order from a lead wafer-level AI processor customer, plus a Q4 beat, record bookings/backlog, stronger fiscal 2027 outlook, and a 53% 21-day gain. | Closed | -14.1% |
| Apr 30 | May 7 | AEHR | Aehr Test Systems | Multiple AI/data-center order wins create strong near-term evidence, including an April 16 record $41M follow-on order from a lead hyperscale customer. Fiscal Q3 bookings were $37.2M with book-to-bill above 3.5x, and the stock gained about 129% over 21 trading days. | Closed | +0.8% |
| Apr 20 | Apr 27 | AEHR | Aehr Test Systems | One of the clearest fresh catalyst setups: record $41 million follow-on order announced on 2026-04-16 and $37.2 million bookings with book-to-bill above 3.5x on 2026-04-07. Shares surged about 160% over 21 trading days, showing exceptional momentum tied to AI-related burn-in demand. | Closed | -1.8% |
| Apr 13 | Apr 20 | AEHR | Aehr Test Systems | AEHR shows classic speculative heat: ~102% 21âday price surge, strong order bookings (bookâtoâbill >3.5x, AI/datacenter and silicon photonics wins) and raised 2H FY26 bookings visibility, making it a highâvolatility, orderâdriven momentum trade over the coming sessions. | Closed | +25.8% |
| Apr 2 | Apr 9 | AEHR | Aehr Test Systems | High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25â30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup. | Closed | +55.4% |
| Mar 9 | Mar 16 | AEHR | Aehr Test Systems | Semicap name with stacked recent orders: in Febâearly Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg. | Closed | -8.3% |
| Feb 23 | Mar 2 | AEHR | Aehr Test Systems | An initial production purchase order from a leading hyperscaler for multiple Sonoma systems and more than $5.5m in recent Q3 orders, tied to nextâgen AI processors, is catalyzing strong technical momentum (break around $34) and elevated investor interest, positioning AEHR for nearâterm upside as those orders convert to reported revenue despite weak recent cash flow and margins. | Closed | +28.3% |
| Dec 17 | Dec 24 | AEHR | Aehr Test Systems | Record Q3 revenues with strong AI/data center product demand, production capacity expansion, institutional buying, and improving gross margins underpin short-term growth, although unprofitability and technical price volatility suggest cautious optimism. | Closed | +2.7% |